NDI
Venture capitalCleveland · Seed–Series A · 14 people tracked
Investment thesis
NDI invests exclusively in innovative neurodevice technologies designed to restore lost neurological function, prevent neurological damage, and reduce the painful effects of disease and injury. As a hybrid venture capital and commercialization firm, it provides capital to identify and develop technologies, launch and grow companies, and take them through to successful exits.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website & public directoriesWhat they invest in
from 3 of 4 portfolio companiesHealthtech ×3Biotech ×1Medical Devices ×1
HQs:United States×3
Investments · 4 tracked
founders shown can be your intro pathBy year:2019 · 12015 · 12 dated
HealthtechCleveland, US
Maria E. Bennett(Executive Officer, Director)Josh Boggs(Executive Officer)Mark Stulz(Executive Officer)Marilyn A. Eisele(Executive Officer)
BoardLes C. Vinney(Director)
Board seatGeoffrey B. Thrope· per SEC Form D
Checkpoint Surgical develops intraoperative nerve stimulation devices, biomaterial implants, and surgical instruments for peripheral nerve and tendon surgery.
BiotechHealthtechMedical DevicesCleveland, US
Marilyn A. Eisele(Executive Officer)Kevin M. Scanlan(Executive Officer)Donald Hubbard(Executive Officer)
BoardTracy Marshbanks(Director)Geoffrey B. Thrope(Executive Officer, Director)Leonard M. Cosentino(Executive Officer, Director)
HealthtechCleveland, US
Leonard Cosentino(Executive Officer, Director)
BoardWarren M. Grill(Executive Officer, Director)Geoffrey B. Thrope(Executive Officer, Director)
Peripheral nerve stimulation system for multiple pain management indications.
Frequently asked questions
- What stage does NDI invest at?
- NDI invests at the Seed, Series A stages.
- What sectors does NDI focus on?
- NDI focuses on Biotech, Hardware, Healthtech, Medical Devices.
- Where is NDI located?
- NDI is headquartered in Cleveland, US.
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Excell Partners manages a state-supported fund in partnership with the University of Rochester and New York State, offering pre-seed and seed stage capital to early-stage technology companies in Upstate New York.











